Basic Information
RNALocate ID: RLID:11001311
RNA Symbol: hsa-miR-129-5p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-129-5p
RNA ID: miRBase:MIMAT0000242
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 21505438
Tissue/Cell Line: Jurkat-derived T cell line (J77cl20)
Method: Microarray
Description: Microarray analysis of exosomal miRNAs verses the miRNAs of their respective donor cells. Data are collected from Supplementary Data 1.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:11001312 Exosome Renal cancer cells 21670082
RLID:11001313 Exosome Brain tissue 23382797
RLID:11001314 Exosome Plasma 23663360
RLID:11001315 Exosome Human mast cell line (HMC-1) 24009880
RLID:11001316 Microvesicle Cerebrospinal fluid 24797360
RLID-D:11000040 Exosome Blood
RLID-D:11000309 Microvesicle Blood|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-129-5p Multiple sclerosis chronic progressive MNDR-E-MI-09946
MNDR hsa-miR-129-5p Medulloblastoma MNDR-E-MI-09947
MNDR hsa-miR-129-5p Uterine corpus endometrial carcinoma MNDR-E-MI-09948
MNDR hsa-miR-129-5p Autism spectrum disorder MNDR-E-MI-09949
MNDR hsa-miR-129-5p Estrogen-receptor positive breast cancer MNDR-E-MI-09950
MNDR hsa-miR-129-5p Progesterone-receptor positive breast cancer MNDR-E-MI-09951
MNDR hsa-miR-129-5p Triple negative breast cancer MNDR-E-MI-09952
MNDR hsa-miR-129-5p Breast cancer luminal MNDR-E-MI-09953
MNDR hsa-miR-129-5p Small intestine cancer MNDR-E-MI-09954
MNDR hsa-miR-129-5p Prostate cancer MNDR-E-MI-09955
MNDR hsa-miR-129-5p Gastric cancer MNDR-E-MI-09956
MNDR hsa-miR-129-5p Alzheimer disease MNDR-E-MI-09957
MNDR hsa-miR-129-5p Bladder cancer MNDR-E-MI-09958
MNDR hsa-miR-129-5p Esophageal carcinoma MNDR-E-MI-09959
MNDR hsa-miR-129-5p Primary biliary cirrhosis MNDR-E-MI-09960
MNDR hsa-miR-129-5p Huntington disease MNDR-E-MI-09961
MNDR hsa-miR-129-5p Chorea MNDR-E-MI-09962
MNDR hsa-miR-129-5p Cardiovascular disease MNDR-E-MI-09963
MNDR hsa-miR-129-5p Lung cancer MNDR-E-MI-09964
MNDR hsa-miR-129-5p Endometrial cancer MNDR-E-MI-09965
MNDR hsa-miR-129-5p Fragile x syndrome MNDR-E-MI-09966
MNDR hsa-miR-129-5p Parkinson disease MNDR-E-MI-09967
MNDR hsa-miR-129-5p Breast cancer MNDR-E-MI-09968
MNDR hsa-miR-129-5p Thyroid cancer MNDR-E-MI-09969
MNDR hsa-miR-129-5p Pituitary neoplasms MNDR-E-MI-09970
MNDR hsa-miR-129-5p Pancreatic cancer MNDR-E-MI-09971
MNDR hsa-miR-129-5p Malignant melanoma MNDR-E-MI-09972
MNDR hsa-miR-129-5p Rectum adenocarcinoma MNDR-E-MI-09973
MNDR hsa-miR-129-5p Nephroblastoma MNDR-E-MI-09974
MNDR hsa-miR-129-5p Colon cancer MNDR-E-MI-09975
MNDR hsa-miR-129-5p Colon adenocarcinoma MNDR-E-MI-09976
MNDR hsa-miR-129-5p Multiple sclerosis relapsing-remitting MNDR-E-MI-09977
MNDR hsa-miR-129-5p Familial ovarian cancer MNDR-E-MI-09978
MNDR hsa-miR-129-5p Prostate adenocarcinoma MNDR-E-MI-09979
MNDR hsa-miR-129-5p Laryngeal squamous cell carcinoma MNDR-E-MI-09980
MNDR hsa-miR-129-5p Carcinoma ductal breast MNDR-E-MI-09981
MNDR hsa-miR-129-5p Glioblastoma MNDR-E-MI-09982
MNDR hsa-miR-129-5p Astrocytoma MNDR-E-MI-09983
MNDR hsa-miR-129-5p Glioma MNDR-E-MI-09984
MNDR hsa-miR-129-5p Amyotrophic lateral sclerosis MNDR-E-MI-09985
MNDR hsa-miR-129-5p Epilepsy temporal lobe MNDR-E-MI-09986
MNDR hsa-miR-129-5p Osteosarcoma MNDR-E-MI-09987
MNDR hsa-miR-129-5p Chondrosarcoma MNDR-E-MI-09988
MNDR hsa-miR-129-5p Gastric adenocarcinoma MNDR-E-MI-09989
MNDR hsa-miR-129-5p Cervical squamous cell carcinoma MNDR-E-MI-09990
MNDR hsa-miR-129-5p Lung squamous cell carcinoma MNDR-E-MI-09991
MNDR hsa-miR-129-5p Non-small cell lung cancer MNDR-E-MI-09992
MNDR hsa-miR-129-5p Lung adenocarcinoma MNDR-E-MI-09993
MNDR hsa-miR-129-5p Thyroid carcinoma MNDR-E-MI-09994
MNDR hsa-miR-129-5p Medullary thyroid carcinoma MNDR-E-MI-09995
MNDR hsa-miR-129-5p Thyroid medullary carcinoma MNDR-E-MI-09996
MNDR hsa-miR-129-5p Bladder urothelial carcinoma MNDR-E-MI-09997
MNDR hsa-miR-129-5p Pancreatic adenocarcinoma MNDR-E-MI-09998
MNDR hsa-miR-129-5p Myasthenia gravis autoimmune experimental MNDR-E-MI-09999
MNDR hsa-miR-129-5p Kidney renal clear cell carcinoma MNDR-E-MI-10000
MNDR hsa-miR-129-5p Kidney renal papillary cell carcinoma MNDR-E-MI-10001
MNDR hsa-miR-129-5p Clear cell renal cell carcinoma MNDR-E-MI-10002
MNDR hsa-miR-129-5p Cholangiocarcinoma MNDR-E-MI-10003
MNDR hsa-miR-129-5p Lung small cell carcinoma MNDR-E-MI-10004
MNDR hsa-miR-129-5p Breast invasive carcinoma MNDR-E-MI-10005
MNDR hsa-miR-129-5p Hepatocellular carcinoma MNDR-E-MI-10006
MNDR hsa-miR-129-5p Familiar ovarian carcinoma MNDR-E-MI-10007
MNDR hsa-miR-129-5p B-cell lymphoma MNDR-E-MI-10008
MNDR hsa-miR-129-5p Malignant pleural mesothelioma MNDR-E-MI-10009
MNDR hsa-miR-129-5p Hodgkin lymphoma MNDR-E-MI-10010
MNDR hsa-miR-129-5p Burkitt lymphoma MNDR-E-MI-10011
MNDR hsa-miR-129-5p Tonsil cancer MNDR-E-MI-10012
MNDR hsa-miR-129-5p Colorectal cancer MNDR-E-MI-10013
MNDR hsa-miR-129-5p Nasopharynx carcinoma MNDR-E-MI-10014
MNDR hsa-miR-129-5p Ependymoma MNDR-E-MI-10015
MNDR hsa-miR-129-5p Nasopharyngeal cancer MNDR-E-MI-10016
MNDR hsa-miR-129-5p AIDS dementia complex MNDR-E-MI-10017
MNDR hsa-miR-129-5p Stroke lacunar MNDR-E-MI-10018
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ABCB1 Homo sapiens RR00022773
TOP